Colorectal Carcinoma
|
0.310 |
GeneticVariation
|
disease |
UNIPROT |
|
|
|
Alzheimer's Disease
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
We used proteomics to detect differences in protein expression between control, DS and Alzheimer's disease brains: In five individual brain regions of 9 individuals of each group we performed two dimensional electrophoresis with MALDI--identification of proteins and determined mRNA levels of DRP-2.
|
10666674 |
1999 |
Down Syndrome
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
The decrease of mRNA DRP-2 steady state levels in DS along with deteriorated protein expression of this repulsive guidance molecule of the semaphorin/collapsin family, may help to explain deranged migration and histogenesis of DS brain and wiring of AD brain.
|
10666674 |
1999 |
Complete Trisomy 21 Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
The decrease of mRNA DRP-2 steady state levels in DS along with deteriorated protein expression of this repulsive guidance molecule of the semaphorin/collapsin family, may help to explain deranged migration and histogenesis of DS brain and wiring of AD brain.
|
10666674 |
1999 |
Alzheimer's Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
The phosphorylation of this particular portion carboxyl-terminal to the basic region of CRMP-2 may play an important role in regulating its activity, and may be involved in the formation of degenerating neurites in AD brain.
|
10757975 |
2000 |
Hypothyroidism
|
0.200 |
Biomarker
|
disease |
RGD |
Significant higher CRMP-2 protein but not CRMP-4 protein was found in the hypothyroid rats.
|
11694350 |
2001 |
Down Syndrome
|
0.020 |
AlteredExpression
|
disease |
LHGDN |
Evaluation of DRP-2, DRP-3 and DRP-4 revealed significantly decreased levels of 2 of the 15 spots assigned to DRP-2 and increased levels of one spot assigned to DRP-3 and increased DRP-4 in DS brain.
|
11771764 |
2001 |
Paranoid Schizophrenia
|
0.320 |
Biomarker
|
disease |
BEFREE |
The human dihydropyrimidinase-related protein 2 gene on chromosome 8p21 is associated with paranoid-type schizophrenia.
|
12679234 |
2003 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that the *2236C allele in the 3'UTR of the DRP-2 gene, or an unknown mutation in linkage disequilibrium with this allele, may reduce the susceptibility to schizophrenia, especially the paranoid subtype.
|
12679234 |
2003 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
No association between the dihydropyrimidinase-related protein 2 (DRP-2) gene and bipolar disorder in humans.
|
12951196 |
2003 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
BEFREE |
No association between the dihydropyrimidinase-related protein 2 (DRP-2) gene and bipolar disorder in humans.
|
12951196 |
2003 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recently, we demonstrated a significant association between the DRP-2 gene and schizophrenia.
|
12951196 |
2003 |
Borderline Personality Disorder
|
0.020 |
Biomarker
|
disease |
BEFREE |
The present study did not provide any evidence for a contribution of the DRP-2 gene to susceptibility to BPD.
|
12951196 |
2003 |
Bronchopulmonary Dysplasia
|
0.020 |
Biomarker
|
disease |
BEFREE |
The present study did not provide any evidence for a contribution of the DRP-2 gene to susceptibility to BPD.
|
12951196 |
2003 |
Neuroblastoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Here we show that glial cell line-derived neurotrophic factor (GDNF) enhances CRMP-2 expression in TGW human neuroblastoma cells via activation of RET receptor tyrosine kinase.
|
15207709 |
2004 |
Central neuroblastoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Here we show that glial cell line-derived neurotrophic factor (GDNF) enhances CRMP-2 expression in TGW human neuroblastoma cells via activation of RET receptor tyrosine kinase.
|
15207709 |
2004 |
Childhood Neuroblastoma
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Here we show that glial cell line-derived neurotrophic factor (GDNF) enhances CRMP-2 expression in TGW human neuroblastoma cells via activation of RET receptor tyrosine kinase.
|
15207709 |
2004 |
Epilepsy, Temporal Lobe
|
0.010 |
Biomarker
|
disease |
LHGDN |
Reduction of hippocampal collapsin response mediated protein-2 in patients with mesial temporal lobe epilepsy.
|
15672539 |
2004 |
Alzheimer's Disease
|
0.400 |
Biomarker
|
disease |
BEFREE |
The dual-phosphorylated CRMP2, but not non-phosphorylated or single-phosphorylated CRMP2, is recognized with the antibody 3F4, which is highly reactive with the neurofibrillary tangles of Alzheimer's disease.
|
15676027 |
2005 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
LHGDN |
We conclude that the DRP-2 *2236 C allele may mark another polymorphism in DRP-2, or in a nearby gene, that may influence susceptibility to schizophrenia.
|
15858820 |
2005 |
Schizophrenia
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We conclude that the DRP-2 *2236 C allele may mark another polymorphism in DRP-2, or in a nearby gene, that may influence susceptibility to schizophrenia.
|
15858820 |
2005 |
Schizophrenia
|
0.100 |
Biomarker
|
disease |
BEFREE |
Case-control and TDT analyses were performed to detect association of DPYSL2 with schizophrenia.
|
16321170 |
2006 |
Bipolar Disorder
|
0.330 |
Biomarker
|
disease |
PSYGENET |
We have previously demonstrated that the DRP-2 gene is associated with susceptibility to schizophrenia, but not to bipolar disorders.
|
17105906 |
2006 |
Bipolar Disorder
|
0.330 |
GeneticVariation
|
disease |
BEFREE |
We have previously demonstrated that the DRP-2 gene is associated with susceptibility to schizophrenia, but not to bipolar disorders.
|
17105906 |
2006 |
Paranoid Schizophrenia
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
The polymorphism *2236T>C in the 3' untranslated region of the DRP-2 gene, which has been shown to be a negative genetic risk factor for paranoid-type schizophrenia, was analyzed in 198 patients with METH psychosis and 221 corresponding healthy controls in a Japanese population.
|
17105906 |
2006 |